Antibiotics: Recover the lost art of drug discovery

Nature

Volumn 485, Issue 7399, 2012, Pages 439-440

  Lewis, Kim ^a,b,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b NovoBiotic Pharmaceuticals   (United States)

^c Arietis Corporation in Boston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G; QUINOLONE DERIVATIVE; STREPTOMYCIN;

BACTERIAL MEMBRANE; DRUG ABSORPTION; DRUG INDUSTRY; DRUG PENETRATION; DRUG SYNTHESIS; GENE EXPRESSION; MYCOBACTERIUM TUBERCULOSIS; NOTE; PRIORITY JOURNAL; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; DAPTOMYCIN; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; HISTORY, 20TH CENTURY; PRODRUGS;

EID: 84861423745     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/485439a     Document Type: Note

References (4)

1. Bush, K. et al. Nature Rev. Microbiol. 9, 894-896 (2011).
2. Alekshun, M. N. & Levy, S. B. Cell 128, 1037-1050 (2007).
3. Lewis, K. Annu. Rev. Microbiol. 64, 357-372 (2010).
4. Lewis, K., Epstein, S., D'Onofrio, A. & Ling, L. L. J. Antibiot. (Tokyo) 63, 468-476 (2010).